• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 14
  • 3
  • 1
  • 1

PRICE

0
1
1
19

PUBLISHED

0
3
15
19

PRODUCT TYPE

19

Search "Transgene Biotek Limited-Therapeutic Competitors Report" returned 19 results.

PRODUCT TITLE
Competitor Analysis: Erythropoietin (EPO) Competitor Analysis: Erythropoietin (EPO) - Product Thumbnail Image

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

January 2011
FROM

Metastatic Liver Cancer - Pipeline Review, H1 2014

Metastatic Liver Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Liver Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Liver Cancer’s therapeutic...

February 2014
FROM

Esophageal Cancer - Pipeline Review, H2 2014

Esophageal Cancer - Pipeline Review, H2 2014 Summary This, ‘Esophageal Cancer - Pipeline Review, H2 2014’, provides an overview of the Esophageal Cancer’s therapeutic pipeline. This report provides...

November 2014
FROM

Esophageal Cancer - Pipeline Review, H1 2015

Esophageal Cancer - Pipeline Review, H1 2015 Summary This, ‘Esophageal Cancer - Pipeline Review, H1 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline. This report provides...

January 2015
FROM

Colon Cancer - Pipeline Review, H1 2014

Colon Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides...

February 2014
FROM

Metastatic Liver Cancer - Pipeline Review, H2 2014

Metastatic Liver Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Liver Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Liver Cancer’s therapeutic pipeline. This...

July 2014
FROM

Esophageal Cancer - Pipeline Review, H1 2014

Esophageal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2014’, provides an overview of the Esophageal Cancer’s therapeutic pipeline. This...

June 2014
FROM

Colon Cancer - Pipeline Review, H2 2014

Colon Cancer - Pipeline Review, H2 2014 Summary This, ‘Colon Cancer - Pipeline Review, H2 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Metastatic Breast Cancer - Pipeline Review, H1 2014

Metastatic Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Breast Cancer’s therapeutic...

March 2014
FROM

Non-Hodgkin Lymphoma - Pipeline Review, H1 2014

Non-Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline. This...

February 2014
FROM

Non-Hodgkin Lymphoma - Pipeline Review, H2 2014

Non-Hodgkin Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline. This report...

October 2014
FROM

Type 2 Diabetes - Pipeline Review, H2 2014

Type 2 Diabetes - Pipeline Review, H2 2014 Summary This, ‘Type 2 Diabetes - Pipeline Review, H2 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Multiple Sclerosis - Pipeline Review, H1 2014

Multiple Sclerosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This...

March 2014
FROM

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014 Summary This, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014’, provides an overview of the Multiple Myeloma (Kahler's...

September 2014
FROM

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2014

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2014 Summary This, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2014’, provides an overview of the Type 1 Diabetes (Juvenile...

October 2014
FROM

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2014

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2014’, provides an overview of the Multiple...

March 2014
FROM

Metastatic Breast Cancer - Pipeline Review, H2 2014

Metastatic Breast Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline. This...

November 2014
FROM

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015 Summary This, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Type 2 Diabetes - Pipeline Review, H1 2015

Type 2 Diabetes - Pipeline Review, H1 2015 Summary This, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group